Dr. Reddy's Laboratories
(NYSE) RDY
Dr. Reddy's Laboratories Financials at a Glance
Market Cap
$12.81B
Revenue (TTM)
₹337.10B
Net Income (TTM)
₹42.88B
EPS (TTM)
$0.59
P/E Ratio
26.19
Dividend
$0.09
Beta (Volatility)
0.43 (Low)
Dividend
$0.09
Beta (Volatility)
0.43 (Low)
Price
$15.40
Volume
124,508
Open
$15.37
Price
$15.40
Volume
124,508
Open
$15.37
Previous Close
$15.40
Daily Range
$15.30 - $15.66
52-Week Range
$12.19 - $15.67
Estimated Earnings Date
Jul 22, 2026
Dividend
$0.09
Beta (Volatility)
0.43 (Low)
Price
$15.40
Volume
124,508
Open
$15.37
Previous Close
$15.40
Daily Range
$15.30 - $15.66
52-Week Range
$12.19 - $15.67
Estimated Earnings Date
Jul 22, 2026
RDY News
What Is an Emerging Market Economy?
Is Dr. Reddy's Laboratories a Buy?
RDY: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Dr. Reddy's Laboratories
Industry
Pharmaceuticals
Sector
Health CareEmployees
27,811
CEO
Erez Israeli, MBA
Website
www.drreddys.comHeadquarters
Hyderabad, 500034, IN
RDY Financials
Key Financial Metrics (TTM)
Gross Margin
52.77%
Operating Margin
14.79%
Net Income Margin
12.76%
Return on Equity
11.76%
Return on Capital
10.97%
Return on Assets
7.40%
Earnings Yield
3.82%
Dividend Yield
0.59%
Payout Ratio
15.54%
Stock Overview
Market Cap
$12.81B
Shares Outstanding
832.66M
Volume
124.51K
Avg. Volume
2.48M
Financials (TTM)
Gross Profit
₹177.79B
Operating Income
₹49.70B
EBITDA
₹77.27B
Operating Cash Flow
₹56.55B
Capital Expenditure
-₹32.29B
Free Cash Flow
₹24.26B
Cash & ST Invst.
₹86.08B
Total Debt
₹75.81B
Dr. Reddy's Laboratories Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
₹76.33B
-10.3%
Gross Profit
₹34.22B
-27.6%
Gross Margin
44.82%
N/A
Market Cap
$12.81B
N/A
Market Cap/Employee
$473.47K
N/A
Employees
27,048
N/A
Net Income
₹2.24B
-86.0%
EBITDA
₹8.76B
-65.3%
Quarterly Fundamentals
Total Cash
₹86.08B
+48.6%
Total Debt
₹75.81B
+62.1%
Accounts Receivable
₹99.22B
-9.6%
Inventory
₹75.02B
+5.5%
Long Term Debt
₹11.96B
+52.1%
Short Term Debt
₹63.85B
+64.1%
Return on Assets
7.40%
N/A
Return on Invested Capital
12.07%
N/A
Free Cash Flow
₹10.75B
-0.0%
Operating Cash Flow
₹15.44B
-29.8%